These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 17226007)

  • 21. Pathogenesis of non-alcoholic steatohepatitis: human data.
    Edmison J; McCullough AJ
    Clin Liver Dis; 2007 Feb; 11(1):75-104, ix. PubMed ID: 17544973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphology of alcoholic liver disease.
    Lefkowitch JH
    Clin Liver Dis; 2005 Feb; 9(1):37-53. PubMed ID: 15763228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nonalcoholic steatohepatitis: a review].
    Jacquemin G
    Rev Med Liege; 2003 Mar; 58(3):147-54. PubMed ID: 12723508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?
    Yilmaz Y
    Aliment Pharmacol Ther; 2012 Nov; 36(9):815-23. PubMed ID: 22966992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology, pathogenesis and histopathology of fatty liver disease.
    Levene AP; Goldin RD
    Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of nonalcoholic steatohepatitis: an analytic review.
    Agrawal S; Bonkovsky HL
    J Clin Gastroenterol; 2002 Sep; 35(3):253-61. PubMed ID: 12192203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
    Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
    Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
    World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
    Schuppan D; Schattenberg JM
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
    Serfaty L; Lemoine M
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and diagnosis of NAFLD/NASH.
    Hashimoto E; Taniai M; Tokushige K
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on the treatments of non-alcoholic fatty liver disease (NAFLD).
    Quercioli A; Montecucco F; Mach F
    Cardiovasc Hematol Disord Drug Targets; 2009 Dec; 9(4):261-70. PubMed ID: 19751186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic fatty liver disease.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2002; 2(1):11-9. PubMed ID: 12122975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Definition and management of non-alcoholic steatohepatitis (NASH)].
    Hütteroth TH
    Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S64-7. PubMed ID: 11450617
    [No Abstract]   [Full Text] [Related]  

  • 36. [Alcoholic liver disease].
    Bell H
    Tidsskr Nor Laegeforen; 1988 Aug; 108(23):1768-72. PubMed ID: 3420581
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease.
    Mills SJ; Harrison SA
    Curr Gastroenterol Rep; 2005 Feb; 7(1):32-6. PubMed ID: 15701296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-alcoholic steatohepatitis: an overview.
    Shifflet A; Wu GY
    J Formos Med Assoc; 2009 Jan; 108(1):4-12. PubMed ID: 19181602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
    Anderson N; Borlak J
    Pharmacol Rev; 2008 Sep; 60(3):311-57. PubMed ID: 18922966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical update on non-alcoholic fatty liver disease and steatohepatitis.
    Bugianesi E; Bellentani S; Bedogni G; Tiribelli C;
    Ann Hepatol; 2008; 7(2):157-60. PubMed ID: 18626435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.